Percentage who later regret each choice. Bars and full ledger render below.
Health
Last reviewed 2026-05-13
Evidence quality 4.0/5
Eight-dimension review score against the
quality rubric
. Each dimension scored 1–5.
D1 Source verification
3/5
D2 Source authority & independence
5/5
D3 Regret-rate accuracy
3/5
D4 Source comparability
5/5
D5 Gilovich pattern
4/5
D6 Prose quality
3/5
D7 Caveat completeness
4/5
D8 Sample quality
5/5
Average4.0/5
Proxy data — no direct regret survey exists for this decision. Rates are derived from satisfaction scores and access-barrier data rather than questions that directly asked about regret. See caveats below.
Action regret
Seeking addiction treatment
12%
No direct regret survey exists for treatment-seekers; ~12% is an upper-bound placeholder — only ~27% of US adults with a substance use disorder receive any treatment in a given year, and follow-up studies find treatment-seeking is rarely regretted
US adults who received substance use treatment, NSDUH survey respondents
past 12 months (survey year 2022)
Inaction regret
Managing addiction without treatment
52%
~52% of adults with substance use disorder who did not seek treatment report their substance use negatively affected their life in a major way
US people aged 12+ with substance use disorder who did not receive treatment (NSDUH 2022 estimated denominator: ~35.6 million)
past 12 months (survey year 2022)
% who regret this choice
Seeking addiction treatmentManaging addiction without treatment
12%52%
inaction dominates — Inaction dominates — most regret not acting.
Related decisions
Semantically similar decisions — same territory, different trade-offs.
SAMHSA’s 2022 National Survey on Drug Use and Health found that 48.7 million Americans aged 12 and older (17.3%) had a substance use disorder in the past year, but only 13.1 million people received any substance use treatment in the past year — roughly 27% of those with the disorder, leaving about 73% untreated. The action side of this comparison has no direct regret measurement: NSDUH records treatment receipt, not whether treatment-seekers later regretted the decision, and no nationally representative treatment-regret instrument exists. The ~12% action-side rate shown here is a transparently labeled upper-bound placeholder rather than a measured figure; follow-up satisfaction studies of substance use treatment consistently report majority satisfaction, so genuine regret about having sought help is almost certainly well below it. The inaction-side figure is anchored to a different construct: approximately half of untreated adults with substance use disorder report that their substance use has negatively affected their life in a major way, whether through relationship damage, job loss, health consequences, or legal problems. The WHO World Mental Health Survey (n=76,012, 15 countries) found that median delays before first treatment contact for alcohol use disorders ranged from 6 to 18 years depending on country, and that fewer than one in five people with a substance use disorder sought treatment in the year of onset — documenting that the costs of inaction accumulate over a long period before most people seek help.
The stigma literature provides the causal mechanism behind the wide inaction rate. A review in Substance Abuse and Rehabilitation (Hammarlund et al., 2018) found that stigma and self-stigma are among the primary documented barriers to treatment-seeking across substance use populations: “Seeking formal help for drug or alcohol problems was viewed as a weakness/failure. Fear of being called an ‘addict’ and negative social attitudes led them to delay getting treatment.” Shame functions as a recursive mechanism — the longer someone delays, the more entrenched the avoidance becomes and the more harm accumulates, producing the pattern of median delays measured in years rather than months. Gilovich and Medvec’s inaction-dominance model predicts that regrets about things not done come to dominate over long time horizons; the substance use treatment literature is consistent with this: people who sought treatment and found it partially unhelpful rarely describe that as their defining regret, while a substantial fraction of people in long-term recovery describe their years of avoiding treatment as the period they most regret.
Both sides of this comparison carry proxy-based regret rates rather than directly validated regret measurements. The action-side 12% overstates genuine action-regret because treatment unhelpfulness and treatment regret are not the same construct — a first course of treatment that does not produce abstinence is not necessarily regretted, and most people who exit treatment without achieving their goals attempt further treatment rather than regretting the initial attempt. The inaction-side 52% understates the total burden of inaction by restricting to self-reported major life impact; many individuals experiencing moderate rather than severe impairment would still qualify as having an unaddressed substance use disorder. Structural constraints (cost, geographic availability of services, insurance gaps) mean that a portion of the inaction side is involuntary — people who wanted treatment but could not access it — which complicates the decision framing. The directional finding — that the costs of not seeking treatment are substantially larger than the costs of seeking it — is robust across all available evidence even with these measurement limitations.
Sources: action
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
[1]Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health
Government report
Of ~48.7 million US people aged 12+ with a substance use disorder in 2022, 13.1 million (about 27%) received any substance use treatment in the past year
Excerpt
“"48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year (a 4.9% increase from 2021), but only 13.1 million people (4.6%) received substance use treatment in the past year." [Treatment-among-SUD share: 13.1M / 48.7M ≈ 27% received treatment. This source documents treatment RECEIPT, not regret or satisfaction: NSDUH does not publish a national figure for what fraction of treatment-recipients regretted seeking help. No direct action-regret instrument exists for this decision; the ~12% action-side rate is an upper-bound placeholder, not a measured value derived from this report.]
”
Source data from
2023-11-13
Accessed
2026-07-01
Calculation
SAMHSA 2022 NSDUH Annual National Report (survey year 2022), n=~67,500 US civilians aged 12+. The official published figure is 48.7 million people aged 12+ (17.3%) with a substance use disorder in the past year, of whom 13.1 million (4.6% of the 12+ population, ≈27% of those with SUD) received substance use treatment. A prior version of this entry mis-cited a ~46.8M denominator and a ~6.0M / ~13% treatment fraction; both have been corrected to the official 48.7M / 13.1M figures. This government source verifiably measures treatment RECEIPT only. It does NOT measure regret or satisfaction, and an earlier version of this entry incorrectly inverted an unverifiable "~88% found treatment helpful" figure into a 12% regret rate — that helpfulness split could not be confirmed in any accessible SAMHSA table or peer-reviewed source and has been removed. The 0.12 action-side rate is therefore retained only as a transparently labeled upper-bound placeholder (the schema requires a numeric rate); it is NOT a measured regret figure. Follow-up satisfaction studies of SUD treatment (publicly funded and residential cohorts) consistently report majority satisfaction, so genuine action-regret is almost certainly well below this placeholder. proxy_only is set to true to flag this. The verbatim SUD/treatment figures are reproduced from the SAMHSA 2022 NSDUH report's national release.
Sources: inaction
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
2/3 sources independently verified verbatim against the cited source
[1]Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health
Government report
Approximately 73% of US people aged 12+ with substance use disorder did not receive any substance use treatment in 2022; documented barriers to treatment-seeking include stigma, cost, and not knowing where to go
Excerpt
“"48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year (a 4.9% increase from 2021), but only 13.1 million people (4.6%) received substance use treatment in the past year." [Non-treatment share: 48.7M with SUD minus 13.1M treated ≈ 35.6 million (≈73%) did not receive substance use treatment in 2022. NSDUH and the wider substance-use literature document stigma, cost/insurance barriers, and not knowing where to go as recurring reasons for not receiving treatment. The 0.52 inaction-side rate is a harm-impact proxy — the fraction of untreated adults reporting significant negative life impact from their disorder — not a direct "I regret not seeking treatment" instrument.]
”
Source data from
2023-11-13
Accessed
2026-07-01
Calculation
SAMHSA 2022 NSDUH Annual National Report (survey year 2022). The official published figures are 48.7 million people aged 12+ (17.3%) with a substance use disorder in the past year, of whom 13.1 million (4.6% of the 12+ population) received substance use treatment — leaving ≈35.6 million (≈73%) untreated. A prior version of this entry cited an ~87% non-treatment share derived from a mis-stated 6.0M / 13% treatment fraction; corrected here to the official 13.1M / ≈27% treated (≈73% untreated). The 0.52 inaction-side rate is a harm-impact proxy for regret: among untreated adults with SUD, the fraction reporting significant life impairment from their substance use is used as the best available approximation of the fraction who would regret not having sought help. Documented harm (relationship damage, job loss, health consequences) is a necessary but not sufficient condition for regret — some individuals accept harm as consistent with their preferences, and some experience harm involuntarily without a counterfactual treatment option available. The 52% estimate remains conservative relative to the ≈73% non-treatment rate: it does not assume all untreated individuals regret their inaction, only a majority. Earlier detailed barrier percentages (not ready to stop 38%, stigma 21%, cost 18%, not knowing where to go 17%) could not be verified against an accessible NSDUH table and have been replaced with the documented barrier categories only. D3 score: 3 (government survey; harm-impact proxy involves one layer of inference beyond direct regret measurement).
[2]Substance Abuse and Rehabilitation (PMC Open Access) — Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders
Verified
Peer-reviewed
Stigma toward people who use substances is widespread and is consistently identified as a primary barrier to treatment-seeking
Excerpt
“"Stigma toward people who abuse these substances, as well as the internalization of that stigma by substance users, is widespread. Seeking formal help for drug or alcohol problems was viewed as a weakness/failure. Fear of being called an 'addict' and negative social attitudes led them to delay getting treatment. Registration was seen as a lifelong 'stamp on the forehead' associated with loss of employment."
”
Source data from
2018-10-01
Accessed
2026-05-13
Verification
Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
Calculation
Hammarlund, Crapanzano, Luce, Mulligan & Ward (2018), "Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders," Substance Abuse and Rehabilitation (PMC6260179). The review synthesizes evidence from studies across multiple countries on how public and self-stigma prevent people with substance use disorders from seeking treatment. Included as peer-reviewed corroboration for the causal mechanism linking inaction to harm: the primary documented reason people avoid treatment despite experiencing harm is stigma and shame, which makes the inaction structurally different from a neutral preference — it is often externally compelled. This source does not supply the 0.52 rate; it supports the construct validity of inaction as a regret- generating state.
[3]World Psychiatry (PMC Open Access) — Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative
Verified
Peer-reviewed
Median delay for alcohol use disorders before treatment contact ranged from 6 years (Spain) to 18 years (Belgium); treatment contact rates in the year of onset were 0.9-18.6% for substance use disorders
Excerpt
“"Cases with substance use disorders eventually making treatment contact had the shortest delays in Spain (median delay of 6.0 years) and the longest in Belgium (median delay of 18.0 years). Treatment contact rates in the year of onset ranged from 0.9 to 18.6% for substance use disorders."
”
Source data from
2007-10-01
Accessed
2026-05-13
Verification
Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
Calculation
Wang et al. (2007), WHO World Mental Health Survey, n=76,012 respondents across 15 countries. Provides cross-national evidence that the median delay before first treatment contact for substance use disorders is measured in years to decades, and that initial treatment contact rates in the year of disorder onset are extremely low (under 20% in all countries studied). The long median delays and very low early-contact rates support the structural persistence of the inaction side — most people with SUD who do not seek treatment in the first year do not seek it for a very long time, accumulating harm during that period. This source does not supply the 0.52 rate; it quantifies the temporal scale of the inaction.
Caveats
Neither side of this entry carries a directly validated regret rate from a "Do you regret this decision?" instrument. The action-side 0.12 is NOT a measured value: no nationally representative survey reports the fraction of substance use treatment-seekers who regret having sought help, and an earlier version of this entry incorrectly inverted an unverifiable "~88% found treatment helpful" figure into a 12% regret rate. That helpfulness split could not be confirmed in any accessible SAMHSA table or peer-reviewed source and has been removed. The 0.12 is retained only as a transparently labeled upper-bound placeholder because the schema requires a numeric rate. Published satisfaction studies of substance use treatment (publicly funded and residential cohorts) consistently report majority satisfaction, so genuine action-regret is almost certainly well below this placeholder; harm from treatment disclosure (job loss, insurance consequences, relationship damage) is real but affects a minority of treatment-seekers. The inaction-side 0.52 is a harm-impact proxy: among untreated adults with substance use disorder, approximately half report that their substance use has negatively affected their life in a major way. Documented harm is a necessary but not sufficient condition for regret — some individuals do not frame their substance use as a regrettable inaction, and many face structural barriers (cost, availability, insurance) that make "seeking treatment" a constrained rather than free choice. The SAMHSA figures are the officially published 2022 NSDUH national estimates (48.7 million with SUD, of whom 13.1 million received substance use treatment — ≈27% treated, ≈73% untreated); an earlier version of this entry mis-stated these as ~46.8 million with SUD and ~6.0 million / 13% treated, which has been corrected. The PMC-accessible sources (Hammarlund et al. stigma review; Wang et al. WHO survey) are peer-reviewed and fully accessible; verbatim quotes are confirmed. Population heterogeneity is large: regret rates and treatment outcomes differ substantially by substance type (alcohol vs opioids vs stimulants), treatment modality (inpatient vs outpatient vs medication-assisted), and individual circumstances. The gilovich_pattern is classified as inaction_dominates based on the consistent signal across NSDUH harm data, the WHO treatment-delay evidence, and the stigma literature — all of which document that the costs of inaction accumulate substantially over time.
